Review of NICE's recommendations, 1999-2005
- 25 May 2006
- Vol. 332 (7552) , 1266.1-1268
- https://doi.org/10.1136/bmj.332.7552.1266
Abstract
NICE appraises the clinical and cost effectiveness of health technologies referred to it by the Department of Health. This is different from a scientific assessment and synthesis of the evidence, which is subcontracted to independent academic groups. The two NICE committees appraise this often incomplete evidence. The committees rely on the judgments of their members, who comprise clinicians, health scientists, managers, and patient representatives.Keywords
This publication has 9 references indexed in Scilit:
- Faculty Opinions recommendation of Setting health care priorities in Oregon. Cost-effectiveness meets the rule of rescue.Published by H1 Connect ,2016
- Who Should We Treat?Rights, Rationing, and Resources in the NHSPublished by Oxford University Press (OUP) ,2005
- Comparing estimates of cost effectiveness submitted to the National Institute for Clinical Excellence (NICE) by different organisations: retrospective studyBMJ, 2004
- TRAITÉ DES PRINCES, CONSEILLERS ET AUTRES MINISTRES DE L'ESTAT DE FRANCE: PART 2Royal Historical Society Camden Fifth Series, 2004
- Does NICE have a cost‐effectiveness threshold and what other factors influence its decisions? A binary choice analysisHealth Economics, 2004
- Drug Policy Down Under: Australia's Pharmaceutical Benefits Scheme2004
- PHARMAC and availability of pharmaceuticals.2002
- NICE: faster access to modern treatments? Analysis of guidance on health technologiesBMJ, 2001
- Setting Health Care Priorities in OregonJAMA, 1991